310 248

Cited 8 times in

Characteristics of double heterozygosity for BRCA1 and BRCA2 germline mutations in Korean breast cancer patients

Authors
Noh, JM; Choi, DH; Nam, SJ; Lee, JE; Kim, JW; Kim, SW; Kang, E; Lee, MH; Ahn, SH; Kim, KS; Park, SK; Haffty, BG; Korea Breast Cancer Study Group
Citation
Breast cancer research and treatment, 131(1):217-222, 2012
Journal Title
Breast cancer research and treatment
ISSN
0167-68061573-7217
Abstract
To investigate clinical, pathological, and familial characteristics of Korean patients with double heterozygosity for BRCA1 and BRCA2 mutations, six breast tumors of five patients who carried deleterious mutations in both of the genes were included. Medical records of the patients were reviewed and genetic testing by direct sequencing was undertaken to detect mutations in BRCA1 and BRCA2. Seven frameshift and three nonsense mutations were identified, and four mutations are novel in the Breast Cancer Information Core. There were no Ashkenazi founder mutations detected. The mean age at diagnosis for breast cancer was 33 years. All six tumors were infiltrating ductal carcinoma and poorly differentiated. Pathologic stage was I or II, and immunohistochemistry showed negative immunoreactivity for estrogen receptor and Her-2/neu in all tumors. Positive immunoreactivity for progesterone receptor was found only in one tumor. Three patients had familial history of breast, ovarian or other cancers. One patient who was diagnosed for breast cancer at the age of 26 had two maternal family members of metachronous bilateral breast cancer. Another patient who experienced metachronous bilateral breast cancer had maternal history of ovarian and esophageal cancer. In summary, Korean patients with double heterozygosity for BRCA1 and BRCA2 were young at diagnosis of breast cancer. Tumors were early stage, high grade, and almost triple-negative phenotype. All familial history of breast, ovary or other cancer was maternal. Close surveillance and accurate risk assessment should be provided for the patients with mutations in the both of the genes.
MeSH terms
AdultBRCA1 Protein/*geneticsBRCA2 Protein/*geneticsBreast Neoplasms/diagnosis/*epidemiology/*geneticsDNA Mutational AnalysisFemaleGenetic TestingGerm-Line MutationHeterozygoteHumansMiddle AgedMutationNeoplasm StagingReceptor, erbB-2Receptors, EstrogenReceptors, ProgesteroneRepublic of Korea
DOI
10.1007/s10549-011-1718-5
PMID
21847643
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Surgery
AJOU Authors
김, 구상
Files in This Item:
217-222.pdfDownload
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse